William D. Clark - Jun 2, 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
President and CEO, Director
Signature
/s/ DIANTHA DUVALL, ATTORNEY-IN-FACT FOR WILLIAM CLARK
Stock symbol
GNCA
Transactions as of
Jun 2, 2022
Transactions value $
-$241
Form type
4
Date filed
6/3/2022, 04:11 PM
Previous filing
Jun 2, 2022
Next filing
Nov 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale -$241 -4.02K -1.3% $0.06* 304K Jun 2, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.